John was Chief Financial Officer at Arcutis Biotherapeutics, and Chief Financial Officer at Sienna Biopharmaceutics. John Smither joined MBX Biosciences in 2026.
John Smither is currently
Create your alert
to follow the career of John Smither.
Do you need to know more about John Smither? More results.
Report an error
Update the org chart details of John Smither.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.